The Trump administration announced Thursday a deal to lower the price of weight loss drugs for some Americans. Dr. Bayo Curry-Winchell, founder of Beyond Clinical Walls, joins CBS News 24/7 to discuss the news.
Breakdown
- President Trump announced a plan to lower weight-loss drug prices through partnerships with Eli Lilly and Novo Nordisk. 1s
- Eligible Americans could see their monthly cost for these drugs drop to under $250, down from around $1,500. 14s
- Health Secretary Robert F. Kennedy Junior stated the deal will have a major impact on Americans, as these drugs are widely used and costly. 26s
- Dr. Bio Curry Winchell noted that over 12% of Americans currently use GLP-1 drugs for weight loss. 1m 12s
- A 2018 study found over 8 million prescriptions for GLP-1s, with concerns that their high cost contributes to rising health insurance premiums. 2m 14s